Clinical Trial Update: An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder. [Phase 3]

View source ↗

Summary

An open-label extension study assessing the safety and tolerability of licarbazepine for manic episodes in Bipolar I Disorder. The update summarizes safety data…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Licarbazepine (licarbazepine)

Snippet

Sponsor: Novartis | Conditions: Bipolar I Disorder | Phase 3 | Status: COMPLETED